ChemicalBook >> CAS DataBase List >>Berberine chloride hydrate

Berberine chloride hydrate

CAS No.
68030-18-2
Chemical Name:
Berberine chloride hydrate
Synonyms
BERBERINE CHLORIDE HYDRATE;Berberine chloride monohydrate;Natural Yellow 18 chloride hydrate;Berberine hydrochloride monohydrate
CBNumber:
CB44797027
Molecular Formula:
C20H20ClNO5
Molecular Weight:
389.83
MDL Number:
MOL File:
68030-18-2.mol
MSDS File:
SDS
TDS File:
TDS
Last updated:2026-04-24 14:58:14
Product description Number Pack Size Price
Berberine chloride hydrate 99.78% orb1707573 10mg $70
Berberine Chloride Hydrate 99.84% CS-3213 1g $150
Berberine Chloride Hydrate 99.84% CS-3213 5g $350
Berberine Chloride Hydrate 99.84% CS-3213 100mg $66

Berberine chloride hydrate Properties

storage temp. Store at -20°C
solubility DMSO: ≥ 3.9 mg/mL (10.00 mM); Water: 1.25 mg/mL (3.21 mM)
form Solid
color Light yellow to yellow

Berberine chloride hydrate price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Biorbyt Ltd orb1707573 Berberine chloride hydrate 99.78% 68030-18-2 10mg $70 2026-05-06 Buy
ChemScene CS-3213 Berberine Chloride Hydrate 99.84% 68030-18-2 1g $150 2021-12-16 Buy
ChemScene CS-3213 Berberine Chloride Hydrate 99.84% 68030-18-2 5g $350 2021-12-16 Buy
ChemScene CS-3213 Berberine Chloride Hydrate 99.84% 68030-18-2 100mg $66 2021-12-16 Buy
Product number Packaging Price Buy
orb1707573 10mg $70 Buy
CS-3213 1g $150 Buy
CS-3213 5g $350 Buy
CS-3213 100mg $66 Buy

Berberine chloride hydrate Chemical Properties,Uses,Production

Uses

Berberine chloride hydrate (Natural Yellow 18 chloride hydrate) is an alkaloid that acts as an antibiotic. Berberine chloride hydrate induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties[1].

Biological Activity

Berberine chloride hydrate (Natural Yellow 18 chloride hydrate) is an alkaloid isolated from Chinese herbal medicine Coptis chinensis and is commonly used as an antibiotic. Berberine chloride hydrate induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase.

in vitro

Berberine chloride hydrate ( Natural Yellow 18 chloride hydrate; 1.25-160 μM; 72 hours) has potential inhibitory effects on the proliferation of four colorectal carcinoma cell lines LoVo, HCT116, SW480, and HT-29.
Berberine chloride hydrate (1.25-160 μM; 24-72 hours) induces a time- and dose-dependent inhibition of LoVo cell growth.
LoVo cells are exposure to Berberine chloride hydrate (10-80 μM) for 24 h. Cell cycle analysis of 40 μM Berberine-treated LoVo cells by flow cytometry shows accumulation of cells in the G2/M phase.
Berberine chloride hydrate (10-80 μM) suppresses cyclin B1, cdc2 and cdc25c protein expression after 24 h, especially at the dose of 80.0 μM.

Cell Proliferation Assay

Cell Line: Four colorectal carcinoma cell lines LoVo, HCT116, SW480, and HT-29
Concentration: 1.25, 2.5, 5, 10, 20, 40, 80, and 160 μM
Incubation Time: 72 hours
Result: < /td> Inhibited the proliferation of four cell lines. The IC 50 ranged from 40.8±4.1 μM (LoVo) to 98.6±2.9 μM (HCT116).

Cell Proliferation Assay

Cell Line: Colorectal carcinoma cell lines LoVo
Concentration: 1.25, 2.5, 5, 10, 20, 40, 80, and 160 μM
Incubation Time: 24, 48, 72 hours
Result: Induced a time- and dose-dependent inhibition of cell growth. By 72 h, 160.0 μM induced 71.1±1.9 % growth inh ibitions in LoVo cells.

Cell Cycle Analysis

Cell Line: LoVo cells
Concentration: 0, 10, 20, 40, or 80 μM
Incubation Time: 24 hours
Result: Exposure to 40.0 μM induced G2/M-phase cell cycle arrest, an increase in the G2/M-phase population and a progressive decline in the G1 population.

Western Blot Analysis

< /tr>
Cell Line: LoVo cells
Concentration: 10, 20, 40, or 80 μM
Incubation Time: 24 hours
Result: Suppressed cyclin B1, cdc2 and cdc25c protein expression.

in vivo

Berberine chloride hydrate (Natural Yellow 18 chloride hydrate; 10, 30, or 50 mg/kg/day; gastrointestinal gavage; for 10 consecutive days) inhibits the growth of human colorectal adenocarcinoma in vivo. Berberine chloride hydrate at Doses of 30 and 50 mg/kg/day taken by gastrointestinal gavage shows inhibitory rates of 33.1% and 45.3% on the human colorectal adenocarcinoma xenograft growth in nude mice.

p>
Animal Model: < /td> 5-week-old BALB/c nu/nu mice with human colorectal adenocarcinoma LoVo xenografts
Dosage : 10, 30, or 50 mg/kg/day
Administration: Gastrointestinal gavage; for 10 consecutive days
Result: Showed inhibitory rates of 33.1 % and 45. 3 % at doses of 30 and 50 mg/kg/day.

target

ROS
DNA topoisomerase

References

[1] Cai Y, et al. Berberine inhibits the growth of human colorectal adenocarcinoma in vitro and in vivo. J Nat Med. 2014 Jan;68(1):53-62. DOI:10.1007/s11418-013-0766-z

68030-18-2
15401-69-1
Synthesis of Berberine chloride hydrate from Berberine chloride hydrate

Berberine chloride hydrate Preparation Products And Raw materials

Raw materials

Preparation Products

Berberine chloride hydrate Suppliers

Global( 24)Suppliers
Supplier Tel Email Country ProdList Advantage
TargetMol Chemicals Inc.
+1-781-999-5354; +17819995354 marketing@targetmol.com United States 32466 58
BOC Sciences 1-631-485-4226; 16314854226 info@bocsci.com United States 12952 65
ShangHai Caerulum Pharma Discovery Co., Ltd. 18149758185 18149758185 sales-cpd@caerulumpharma.com China 3504 58
Shanghai YuanYe Biotechnology Co., Ltd. 021-61312847; 18021002903 3008007409@qq.com China 89686 60
Beijing Jin Ming Biotechnology Co., Ltd. 010-60605840 18892239720 psaitong@jm-bio.com China 12306 58
Fan De(Beijing) Biotechnology Co., Ltd. 15911056312 liming@bio-fount.com China 9729 58
cjbscvictory 13348960310 13348960310 3003867561@qq.com China 10336 58
Shanghai Maclean Biochemical Technology Co., LTD 021-50706066 15221275939 shenlinxing@macklin.cn China 29680 58
Meryer (Shanghai) Chemical Technology Co., Ltd. 18621169109 market03@meryer.com China 27987 58
RD International Technology Co., Limited 18024082417 market@ubiochem.com China 9835 58
Natural Yellow 18 chloride hydrate Berberine hydrochloride monohydrate BERBERINE CHLORIDE HYDRATE Berberine chloride monohydrate 68030-18-2